These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

639 related articles for article (PubMed ID: 33729726)

  • 1. Early Impella Support in Postcardiac Arrest Cardiogenic Shock Complicating Acute Myocardial Infarction Improves Short- and Long-Term Survival.
    Chatzis G; Markus B; Luesebrink U; Ahrens H; Divchev D; Syntila S; Scheele N; Al Eryani H; Tousoulis D; Schieffer B; Karatolios K
    Crit Care Med; 2021 Jun; 49(6):943-955. PubMed ID: 33729726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long term survival after early unloading with Impella CP
    Loehn T; O'Neill WW; Lange B; Pfluecke C; Schweigler T; Mierke J; Waessnig N; Mahlmann A; Youssef A; Speiser U; Strasser RH; Ibrahim K
    Eur Heart J Acute Cardiovasc Care; 2020 Mar; 9(2):149-157. PubMed ID: 30456984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impella 2.5 initiated prior to unprotected left main PCI in acute myocardial infarction complicated by cardiogenic shock improves early survival.
    Meraj PM; Doshi R; Schreiber T; Maini B; O'Neill WW
    J Interv Cardiol; 2017 Jun; 30(3):256-263. PubMed ID: 28419573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impella support compared to medical treatment for post-cardiac arrest shock after out of hospital cardiac arrest.
    Karatolios K; Chatzis G; Markus B; Luesebrink U; Ahrens H; Dersch W; Betz S; Ploeger B; Boesl E; O'Neill W; Kill C; Schieffer B
    Resuscitation; 2018 May; 126():104-110. PubMed ID: 29522829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The current use of Impella 2.5 in acute myocardial infarction complicated by cardiogenic shock: results from the USpella Registry.
    O'Neill WW; Schreiber T; Wohns DH; Rihal C; Naidu SS; Civitello AB; Dixon SR; Massaro JM; Maini B; Ohman EM
    J Interv Cardiol; 2014 Feb; 27(1):1-11. PubMed ID: 24329756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of different mechanical circulatory support devices and their timing of implantation on myocardial damage and mid-term recovery in acute myocardial infarction related cardiogenic shock.
    Pieri M; Sorrentino T; Oppizzi M; Melisurgo G; Lembo R; Colombo A; Zangrillo A; Pappalardo F
    J Interv Cardiol; 2018 Dec; 31(6):717-724. PubMed ID: 30460719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contemporary trends in use of mechanical circulatory support in patients with acute MI and cardiogenic shock.
    Helgestad OKL; Josiassen J; Hassager C; Jensen LO; Holmvang L; Udesen NLJ; Schmidt H; Berg Ravn H; Moller JE
    Open Heart; 2020; 7(1):e001214. PubMed ID: 32201591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Women With Cardiogenic Shock Derive Greater Benefit From Early Mechanical Circulatory Support: An Update From the cVAD Registry.
    Joseph SM; Brisco MA; Colvin M; Grady KL; Walsh MN; Cook JL;
    J Interv Cardiol; 2016 Jun; 29(3):248-56. PubMed ID: 27229327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanical circulatory support in cardiogenic shock from acute myocardial infarction: Impella CP/5.0 versus ECMO.
    Karami M; den Uil CA; Ouweneel DM; Scholte NT; Engström AE; Akin S; Lagrand WK; Vlaar AP; Jewbali LS; Henriques JP
    Eur Heart J Acute Cardiovasc Care; 2020 Mar; 9(2):164-172. PubMed ID: 31353918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left Ventricular Unloading Before Percutaneous Coronary Intervention is Associated With Improved Survival in Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock: A Systematic Review and Meta-Analysis.
    Miyashita S; Banlengchit R; Marbach JA; Chweich H; Kawabori M; Kimmelstiel CD; Kapur NK
    Cardiovasc Revasc Med; 2022 Jun; 39():28-35. PubMed ID: 34824038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of Hemodynamic Support With Impella for Acute Myocardial Infarction Complicated by Cardiogenic Shock at a Rural Community Hospital Without On-Site Surgical Back-up.
    Wilkins CE; Herrera TL; Nagahiro MK; Weathers LB; Girotra SV; Sandhu F
    J Invasive Cardiol; 2019 Feb; 31(2):E23-E29. PubMed ID: 30700627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Comparison of In-Hospital Outcomes Between the Use of Impella and IABP in Acute Myocardial Infarction Cardiogenic Shock Undergoing Percutaneous Coronary Intervention.
    Jin C; Yandrapalli S; Yang Y; Liu B; Aronow WS; Naidu SS
    J Invasive Cardiol; 2022 Feb; 34(2):E98-E103. PubMed ID: 35100554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structured Weaning From the Impella Left Ventricular Micro-Axial Pump in Acute Myocardial Infarction With Cardiogenic Shock and Protected Percutaneous Coronary Intervention: Experience From a Non-Cardiac Surgical Centre.
    Slack RJ; McGain F; Cox N; French C; Cheng V; Stub D; Zakhem B; Dade F; Bloom JE; Chan W; Yang Y
    Heart Lung Circ; 2024 Apr; 33(4):460-469. PubMed ID: 38388259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility of early mechanical circulatory support in acute myocardial infarction complicated by cardiogenic shock: The Detroit cardiogenic shock initiative.
    Basir MB; Schreiber T; Dixon S; Alaswad K; Patel K; Almany S; Khandelwal A; Hanson I; George A; Ashbrook M; Blank N; Abdelsalam M; Sareen N; Timmis SBH; O'Neill Md WW
    Catheter Cardiovasc Interv; 2018 Feb; 91(3):454-461. PubMed ID: 29266676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Timing of Impella implantation and outcomes in cardiogenic shock or high-risk percutaneous coronary revascularization.
    Tarantini G; Masiero G; Burzotta F; Pazzanese V; Briguori C; Trani C; Piva T; De Marco F; Di Biasi M; Pagnotta P; Mojoli M; Casu G; Giustino G; Lorenzoni G; Montorfano M; Ancona MB; Pappalardo F; Chieffo A;
    Catheter Cardiovasc Interv; 2021 Aug; 98(2):E222-E234. PubMed ID: 33793051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-life use of left ventricular circulatory support with Impella in cardiogenic shock after acute myocardial infarction: 12 years AMC experience.
    Ouweneel DM; de Brabander J; Karami M; Sjauw KD; Engström AE; Vis MM; Wykrzykowska JJ; Beijk MA; Koch KT; Baan J; de Winter RJ; Piek JJ; Lagrand WK; Cherpanath TG; Driessen AH; Cocchieri R; de Mol BA; Tijssen JG; Henriques JP
    Eur Heart J Acute Cardiovasc Care; 2019 Jun; 8(4):338-349. PubMed ID: 30403366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of Impella 2.5 in severe refractory cardiogenic shock complicating an acute myocardial infarction.
    Casassus F; Corre J; Leroux L; Chevalereau P; Fresselinat A; Seguy B; Calderon J; Coste P; Ouattara A; Roques X; Barandon L
    J Interv Cardiol; 2015 Feb; 28(1):41-50. PubMed ID: 25689547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Use of an Intravascular Microaxial Left Ventricular Assist Device vs Intra-aortic Balloon Pump With In-Hospital Mortality and Major Bleeding Among Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock.
    Dhruva SS; Ross JS; Mortazavi BJ; Hurley NC; Krumholz HM; Curtis JP; Berkowitz A; Masoudi FA; Messenger JC; Parzynski CS; Ngufor C; Girotra S; Amin AP; Shah ND; Desai NR
    JAMA; 2020 Feb; 323(8):734-745. PubMed ID: 32040163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Timing of impella placement in PCI for acute myocardial infarction complicated by cardiogenic shock: An updated meta-analysis.
    Iannaccone M; Franchin L; Hanson ID; Boccuzzi G; Basir MB; Truesdell AG; O'Neill W
    Int J Cardiol; 2022 Sep; 362():47-54. PubMed ID: 35533755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Mortality Risk Models in Patients with Postcardiac Arrest Cardiogenic Shock and Percutaneous Mechanical Circulatory Support.
    Chatzis G; Markus B; Syntila S; Waechter C; Luesebrink U; Ahrens H; Divchev D; Schieffer B; Karatolios K
    J Interv Cardiol; 2021; 2021():8843935. PubMed ID: 33536855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.